Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH001 in Postpartum Depression
NCT05804708Phase 2Terminated
- Sponsor
- GH Research PLC
- Start
- Mar 2023
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of mebufotenin in postpartum depression (PPD), sponsored by GH Research PLC. Started Mar 2023; status: terminated.
02
Drugs
mebufotenin
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT05804708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05804708.